Metraipolis › archive › dc_f1aa999068da

One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency — Europe PMC PMID:40917874

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40917874
DOI
10.3389/falgy.2025.1636425
License (as archived)
solo-consultazione
Archived
2026-11-10T11:11:44.356Z
SHA-256 of the archived text
6e82b71d619ea194d426c38c38ad2c0e6ef1fd82aa247ba2d0f14bd6eb51243b
Stable URL of this page
https://metraipolis.com/documento/dc_f1aa999068da

How to cite

One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency — Europe PMC PMID:40917874 — Europe PMC (en), https://europepmc.org/article/MED/40917874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f1aa999068da (Metraipolis archive dc_f1aa999068da, sha256 6e82b71d619ea194d426c38c38ad2c0e6ef1fd82aa247ba2d0f14bd6eb51243b)
BibTeX
@misc{dcf1aa999068da,
  title = {One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency — Europe PMC PMID:40917874},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40917874},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f1aa999068da; sha256 6e82b71d619ea194d426c38c38ad2c0e6ef1fd82aa247ba2d0f14bd6eb51243b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40917874. Agents can read the archived copy with the MCP tool read_document.